MabThera in RA (Rituximab)
Indicated for use in combination with methotrexate for reducing signs and symptoms in adult patients with moderately- to severely-active rheumatoid arthritis (RA).
Looking for more detailed information?
For regulatory reasons we are not able to provide further details on our products on this website, but more information may be available on our local website.
Please choose your country of residence to access available information in your language.